Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1Phase 2 1

Status

Completed 10Unknown 7Withdrawn 4Recruiting 4Terminated 3Not yet recruiting 3Active not recruiting 1

Sponsor Class

OTHER 2OTHER_GOV 1INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 4

Conditions

Breast Neoplasms 4Warts 2Pancreatic Neoplasms 2Pain, Postoperative 2Pain 2Lung Neoplasms 2Trauma, Nervous System 1Thrombosis 1Synovial Cyst 1Spondylosis 1Spondylolisthesis 1Spinal Stenosis 1Sleep Initiation and Maintenance Disorders 1Sleep Deprivation 1Schwannomatosis 1Radiculopathy 1Postoperative Complications 1Papillomavirus Infections 1Ovarian Neoplasms 1Non-Muscle Invasive Bladder Neoplasms 1Neurilemmoma 1Multiple Myeloma 1Metastatic Non-Squamous Non-Small Cell Lung Cancer 1Mesothelioma 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Lymphoma 1Lipoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Intracranial Hemorrhages 1

Interventions

Fulvestrant 58Trastuzumab 49Capecitabine 48Letrozole 45pembrolizumab 41Carboplatin 41Paclitaxel 39Cyclophosphamide 38ribociclib 37pertuzumab 36abemaciclib 36Blood Specimen Collection 31Specimen Handling 28trastuzumab deruxtecan 27Docetaxel 27Surveys and Questionnaires 26Anastrozole 25exemestane 24Tamoxifen 24palbociclib 21130-nm albumin-bound paclitaxel 21Magnetic Resonance Spectroscopy 20Biopsy 19sacituzumab govitecan 18eribulin 18Radiotherapy 18Gemcitabine 18olaparib 17Injections 17Epirubicin 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × Breast Neoplasms × Saline Solution × Clear all
NCT05072314 2026-03-25

LOLIPOP

Monash University

Phase 3 Recruiting
4,300 enrolled
Breast

Breast Neoplasms, Pain, Postoperative

NCT06174363 2025-07-20

Analgesic Efficacy of Maxigesic in Breast Cancer Surgery

Yonsei University

Phase NA Recruiting
84 enrolled
Breast

Breast Neoplasms

NCT05440227 2025-06-05

PG2 Injection for the Treatment of moderate-to Severe Fatigue in Breast Cancer Patients

PhytoHealth Corporation

Phase 2 Recruiting
36 enrolled
Breast

Breast Neoplasms, Fatigue

NCT01785420 2025-04-09

Pre Operative Trastuzumab in Operable Breast Cancer

Tata Memorial Hospital

Phase 3 Recruiting
1,100 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡